Keros Therapeutics logo

Keros Therapeutics Share Price Today

(NASDAQ: KROS)

Keros Therapeutics share price is $11.67 & ₹1,014.93 as on 6 Mar 2025, 2.30 'hrs' IST

$11.67

0.08

(0.69%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Keros Therapeutics share price in Dollar and Rupees. Guide to invest in Keros Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Keros Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Keros Therapeutics share price movements

  • Today's Low: $11.22
    Today's High: $11.78

    Day's Volatility :4.71%

  • 52 Weeks Low: $9.78
    52 Weeks High: $72.37

    52 Weeks Volatility :86.49%

Keros Therapeutics (KROS) Returns

PeriodKeros Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-82.06%
2.1%
0.0%
6 Months
-78.41%
-4.1%
0.0%
1 Year
-82.42%
2.2%
0.0%
3 Years
-76.86%
11.8%
-11.6%

Keros Therapeutics (KROS) Key Statistics

in dollars & INR

Previous Close
$11.59
Open
$11.59
Today's High
$11.775
Today's Low
$11.22
Market Capitalization
$450.8M
Today's Volume
$325.9K
52 Week High
$72.37
52 Week Low
$9.775
Revenue TTM
$3.6M
EBITDA
$-209.6M
Earnings Per Share (EPS)
$-4.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-41.46%

How to invest in Keros Therapeutics Stock (KROS) from India?

It is very easy for Indian residents to invest directly in Keros Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Keros Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Keros Therapeutics or KROS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Keros Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Keros Therapeutics shares which would translate to 0.075 fractional shares of Keros Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Keros Therapeutics, in just a few clicks!

Returns in Keros Therapeutics (KROS) for Indian investors in Rupees

The Keros Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Keros Therapeutics investment value today

Current value as on today

₹22,661

Returns

₹77,339

(-77.34%)

Returns from Keros Therapeutics Stock

₹82,302 (-82.3%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Keros Therapeutics (KROS)

-77%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Keros Therapeutics Stock from India on INDmoney has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Keros Therapeutics

  • FMR Inc

    13.67%

  • BlackRock Inc

    6.73%

  • Vanguard Group Inc

    4.83%

  • BRAIDWELL LP

    4.67%

  • Darwin Global Management, Ltd.

    4.16%

  • State Street Corp

    2.97%

Analyst Recommendation on Keros Therapeutics

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Keros Therapeutics(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Keros Therapeutics Stock (KROS)

What analysts predicted

Upside of 188.23%

Target:

$33.64

Current:

$11.67

Insights on Keros Therapeutics Stock (Ticker Symbol: KROS)

  • Price Movement

    In the last 7 days, KROS stock has moved up by 5.9%
  • KROS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 145.0%
  • KROS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 124.1%
  • Price to Sales

    ForKROS every $1 of sales, investors are willing to pay $122.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Keros Therapeutics Technicals Summary

Sell

Neutral

Buy

Keros Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Keros Therapeutics (KROS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Keros Therapeutics Inc logo
5.36%
-78.41%
-82.42%
-76.86%
-77.49%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Keros Therapeutics Inc logo
NA
NA
NA
-2.4
-0.41
-0.27
NA
14.09
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Keros Therapeutics Inc logo
Buy
$450.8M
-77.49%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Keros Therapeutics

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-012, which is in Phase II clinical trial to treat pulmonary arterial hypertension and cardiovascular disorders; and KER-065 that is in Phase I clinical trial for the treatment of obesity and neuromuscular diseases. In addition, the company has collaboration and license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize KER-050 and licensed products containing KER-050. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Organization
Keros Therapeutics
Employees
169
CEO
Dr. Jasbir S. Seehra Ph.D.
Industry
Commercial Services

Management People of Keros Therapeutics

NameTitle
Dr. Jasbir S. Seehra Ph.D.
CEO & Chair of the Board
Mr. Christopher Rovaldi M.Sc.
President & COO
Mr. Keith C. Regnante MBA
Chief Financial Officer
Ms. Esther Cho J.D.
Senior VP, General Counsel & Secretary
Ms. Robin Wagner
Senior Vice President of Human Resources
Mr. John Oram M.B.A.
Senior Vice President of Program & Portfolio Management
Dr. Yung H. Chyung M.D.
Chief Medical Officer

Important FAQs about investing in KROS Stock from India :

What is Keros Therapeutics share price today?

Keros Therapeutics share price today stands at $11.67, Open: $11.59 ; Previous Close: $11.59 ; High: $11.78 ; Low: $11.22 ; 52 Week High: $72.37 ; 52 Week Low: $9.78.

The stock opens at $11.59, after a previous close of $11.59. The stock reached a daily high of $11.78 and a low of $11.22, with a 52-week high of $72.37 and a 52-week low of $9.78.

Can Indians buy Keros Therapeutics shares?

Yes, Indians can invest in the Keros Therapeutics (KROS) from India.

With INDmoney, you can buy Keros Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Keros Therapeutics at zero transaction cost.

How can I buy Keros Therapeutics shares from India?

It is very easy to buy Keros Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Keros Therapeutics (KROS) be purchased?

Yes, you can buy fractional shares of Keros Therapeutics with INDmoney app.

What are the documents required to start investing in Keros Therapeutics stocks?

To start investing in Keros Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Keros Therapeutics Stock (KROS)?

Today’s highest price of Keros Therapeutics (KROS) is $11.78.

Today’s lowest price of Keros Therapeutics (KROS) is $11.22.

What is today's market capitalisation of Keros Therapeutics?

Today's market capitalisation of Keros Therapeutics KROS is 450.8M

What is the 52 Week High and Low Range of Keros Therapeutics Stock (KROS)?

  • 52 Week High

    $72.37

  • 52 Week Low

    $9.78

What are the historical returns of Keros Therapeutics (KROS)?

  • 1 Month Returns

    5.36%

  • 3 Months Returns

    -78.41%

  • 1 Year Returns

    -82.42%

  • 5 Years Returns

    -77.49%

Who is the Chief Executive Officer (CEO) of Keros Therapeutics ?

Dr. Jasbir S. Seehra Ph.D. is the current Chief Executive Officer (CEO) of Keros Therapeutics.